web analytics

Google reveals when will iOS officially adopt RCS

Last year, Apple announced that it’s finally adopting Rich Communication Services (RCS) on iOS. On top of the traditional text messaging, RCS will enable more features between iPhone and Android devices, including high quality media sharing, read receipts, and more.

Rcs On Iphone X Ios Blue Bubble Vs Android Green Bubble Cfi

Now, Google may have inadvertently revealed the timeframe for when Apple will implement RCS support on the iPhone. As first spotted by 9to5Google, Google published a new landing page 58 for its Messages app wherein the RCS segment reads, “Apple has announced it will be adopting RCS in the fall of 2024.”

Google Messages Landing Page Reveals When Will Apple Adopt Rcs (highlighted)

The fall season in the US starts this year on September 22nd. That’s roughly the same month when the next iPhone 16 (running iOS 18) is expected to launch. This suggests that RCS will be one of the key highlights of the iPhone 16 lineup or iOS 18 itself.

Speaking of iOS 18, WWDC 2024 is scheduled on June 10th. Naturally, it will undergo beta testing, and if ever Apple announces RCS support, then beta testers are first to experience the improved messaging experience between the two major mobile operating systems.

Green bubbles are here to stay, though. As explained in our previous article, Apple asserts that RCS simply replaces SMS/MMS services which will “exist separately from iMessage.”

UPDATE: Upon checking the new Google Messages landing page, the said segment under RCS is now removed.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 1,039 other subscribers
Avatar for JM Chavaria

JM's highest stat is probably his curious ardor to anything tech—electronics and gaming in particular. He certainly heeds utmost regard to specsheet, visuals, and rule of thirds. If creativity and wit sometimes leave JM's system, watching films, anime and a good stroll for memes are his approved therapeutic claims.

Leave a Reply

Your email address will not be published. Required fields are marked *